Tan Truong

Tan Truong serves as an Assistant Clinical Professor at the University of California, Berkeley, specializing in clinical research optometry with 20+ years of expertise in ocular immunology and ophthalmic product development. His multifaceted career bridges vision science, molecular biology, and epidemiology to advance translational eye care solutions.

Education:

• PhD in Vision Science, University of California, Berkeley (2015)
• MPH in Epidemiology, University of California, Berkeley (2007)
• OD in Optometry, University of California, Berkeley (2004)
• BA in Molecular and Cell Biology, University of California, Berkeley (1999)

Dr. Truong's research focuses on corneal disease mechanisms, lymphatic vessel development, and contact lens-related ocular surface complications. His work integrates molecular techniques with clinical applications to address inflammatory pathways and microbial infections, particularly Pseudomonas aeruginosa keratitis. He emphasizes creative problem-solving to translate laboratory findings into improved diagnostic and therapeutic approaches.

Analysis of his publication record reveals consistent investigation into corneal lymphangiogenesis, inflammatory responses to contact lens wear, and murine modeling of ocular infections. His studies frequently examine therapeutic interventions like corticosteroids and integrin blockers while exploring novel imaging techniques for Schlemm's canal and lymphatic valves.

Professional Recognition:

• Fellow of the American Academy of Optometry (FAAO)

Dr. Truong actively teaches at UC Berkeley while maintaining a private optometry practice and consulting for the ophthalmic medical device industry. His industry collaborations focus on clinical research and product development, though specific grant details remain undisclosed in available materials. He mentors students through academic instruction and clinical supervision, fostering the next generation of optometric researchers.

His laboratory work employs cross-functional teams specializing in intravital imaging, molecular biology, and epidemiological analysis. Current projects center on accelerating the application of basic science discoveries to clinical practice, particularly in diagnosing and treating ocular inflammation through emerging technologies.